Filter
463
Text search:
Strengthening
Pharmaceutical
Systems
Featured
44
230
Language
Document type
383
29
19
13
8
5
2
1
1
1
1
Countries / Regions
23
23
23
22
22
21
20
17
16
14
12
12
12
11
9
8
7
7
7
6
6
5
5
5
5
5
4
4
4
4
4
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
276
20
19
15
9
8
2
Toolboxes
41
38
26
17
12
7
5
5
5
5
5
4
4
3
2
2
1
1
1
The 6th edition of the essential medicine list has been developed based on the 5th edition list of essential medicines, the National Standard Treatment Guidelines and Protocols 2013, list of laboratory commodities and List of Consumables used in public health facilities.
14–22 April 2015
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO
...
Harmonising proven strategies beyond the emergency phase. Zero Hunger Phase 2
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
BMC Medicine 2014, 12:196
http://www.biomedcentral.com/1741-7015/12/196
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n
...
